Neuland Laboratories receives EIR from USFDA for Bonthapally facility

30 Aug 2019

Neuland Laboratories has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility located at Bonthapally, Hyderabad. The facility was inspected from June 17, 2019 to June 21, 2019.

Neuland Laboratories manufactures active pharmaceutical ingredients for global pharmaceutical companies and provides end-to-end solutions for the pharmaceutical industry for chemistry-related services.

Related Neuland Laboratories Ltd. Links:

Neuland Laboratories Share Price

470.60 7.80 (1.69%) Feb 14, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 418.55
Lupin 717.85
Dr. Reddys Lab 3307.50
Piramal Enterprises 1528.65
Cadila Healthcare 269.85
View more..
Sensex vs Neuland Laboratories
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463